AllSight
Companies · TDOC · Services-Offices & Clinics Of Doctors Of Medicine

Teladoc Health, Inc. (TDOC)

Teladoc Health, Inc. (TDOC) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

Teladoc Health, Inc. (TDOC) stock — financials & valuation

Key numbers for Teladoc Health, Inc. (TDOC): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 37/100 — a percentile rank of Teladoc Health, Inc.’s fundamentals against Services peers, weakest on growth. A quality ranking, not a price prediction.

Market cap$1.0B
P / S0.4×
EV / EBITDA5.7×
Gross margin69.0%
Operating margin-7.4%
Net margin-7.1%
Return on equity-13.5%
ROIC-11.7%
Revenue growth-2.1%
Debt / equity0.8×
Dividend yield0.0%

Is Teladoc Health, Inc. overvalued? P/S looks undervalued vs its 5-year range; EV/EBITDA looks undervalued vs its 5-year range; P/B looks undervalued vs its 5-year range.

Independent of the events above — derived from Teladoc Health, Inc.’s own financial statements and shown as context, never as advice.

Sep 25, 2026CLO departure
Teladoc CLO resigns for “good reason,” with internal successor lined up
Aug 31, 2026CFO appointment
Teladoc names Michael Grasher CFO, but severance terms—not operations—drive the filing
Aug 13, 2026Director retirement
Teladoc loses a longtime director—but the filing flags no internal rift
Related companies in Services-Offices & Clinics Of Doctors Of Medicine
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact